Hepion Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HEPA and other ETFs, options, and stocks.

About HEPA

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. 

CEO
John T. Cavan
CEOJohn T. Cavan
Employees
22
Employees22
Headquarters
Edison, New Jersey
HeadquartersEdison, New Jersey
Founded
2013
Founded2013
Employees
22
Employees22

HEPA Key Statistics

Market cap
7.06M
Market cap7.06M
Price-Earnings ratio
-0.11
Price-Earnings ratio-0.11
Dividend yield
—
Dividend yield—
Average volume
72.66K
Average volume72.66K
High today
$1.34
High today$1.34
Low today
$1.27
Low today$1.27
Open price
$1.30
Open price$1.30
Volume
7.24K
Volume7.24K
52 Week high
$20.66
52 Week high$20.66
52 Week low
$1.22
52 Week low$1.22
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.